ALHC vs ERAS: Which Stock Is the Better Buy?
Alignment Healthcare, Inc. and Erasca, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ALHC vs ERAS, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Alignment Healthcare, Inc. (ALHC) | Erasca, Inc. (ERAS) | |
|---|---|---|
| Market cap | $4.3B | $4.2B |
| Revenue (latest FY) | $3.95B | $0 |
| Net income (latest FY) | $-724,000 | $-124.55M |
| Revenue growth (5y CAGR) | 32.7% | — |
| Net margin | -0.0% | — |
| Return on equity | -0.4% | -38.3% |
| P/E ratio | 205.7 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | Yes | No |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full ALHC vs ERAS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ALHC's full financials → Open ERAS's full financials →More comparisons
Frequently asked questions
Which is bigger, ALHC or ERAS?
Alignment Healthcare, Inc. is larger by market capitalization — $4.3B versus $4.2B.
Which grows faster, ALHC or ERAS?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
ALHC fundamentals → · ERAS fundamentals → · All 1,500+ companies → · Free screener →